Eric Sredzinski, PharmD, AAHIVP

Approximately 80% of manufacturers are already managing their products, many of which are oncology drugs, through a limited distribution model.

Physicians are challenged with differentiating among a wide array of treatment options, with varying regimens and indications, and then monitoring patients according to the specific guidelines for each therapy.

A pharmacy that seeks to register as an outsourcing facility will likely need to make investments in infrastructure and training in order to comply with the Drug Quality and Security Act.